{"id":726159,"title":"ARCHIVED - Literature review on HPV 6, 11, 16 and 18: Disease and Vaccine Characteristics - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-02-05","captureTimestamp":"2026-02-05T16:19:10.115000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/literature-review-on-hpv-6-11-16-18-disease-vaccine-characteristics.html","snippet":"ARCHIVED - Literature review on HPV 6, 11, 16 and 18: Disease and Vaccine Characteristics We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page and will not be updating it. You can use it for research or…","rawSnapshotUrl":"/api/snapshots/raw/726159","browseUrl":"https://replay.healtharchive.ca/job-7/20260205161910/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/literature-review-on-hpv-6-11-16-18-disease-vaccine-characteristics.html#ha_snapshot=726159","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}